VERA · Insider trading · 13F holders · Congress trades
Vera Therapeutics, Inc. (VERA)
Who is buying and selling VERA: company insiders on SEC Form 4, hedge funds and superinvestors on Form 13F, and members of Congress under the STOCK Act. Every figure links to the filing or page it comes from.
- 13F filers holding
- 29
- Insider buys, 90 days
- $0
- Insider sales, 90 days
- $1.3M
- Congress trades, 12 months
- 0
VERA at a glance
- Between Aug 1, 2026 and Oct 29, 2026, 1 VERA insider filed 2 sales worth $1.3M on SEC Form 4, and no open-market purchases; 2 of the sales were pre-planned under Rule 10b5-1.
- 29 13F filers hold VERA among their 50 largest positions, worth $1.3B combined, including Behzad Aghazadeh and James Flynn. The biggest bets by portfolio weight are Kynam Capital Management, LP (6.9%), Sofinnova Investments, Inc. (6.4%) and Great Point Partners LLC (6.1%). In their latest 13Fs, 1 manager opened a new position and 8 added to one.
- No member of Congress has disclosed a trade in VERA.
- VERA last closed at $30.53 on Oct 29, 2026.
VERA insider trading
Between Aug 1, 2026 and Oct 29, 2026, 1 VERA insider filed 2 sales worth $1.3M on SEC Form 4, and no open-market purchases; 2 of the sales were pre-planned under Rule 10b5-1.
| Filed | Insider | Role | Trade | Shares | Price | Value | Form 4 |
|---|---|---|---|---|---|---|---|
| Sep 17, 2026 | Fordyce Marshall | PRESIDENT AND CEO, Director | Sale10b5-1 | 18,500 | $37.00 | $685K | SEC |
| Sep 4, 2026 | Fordyce Marshall | PRESIDENT AND CEO, Director | Sale10b5-1 | 18,500 | $35.12 | $650K | SEC |
Who owns VERA? Hedge funds and superinvestors
29 13F filers hold VERA among their 50 largest positions, worth $1.3B combined, including Behzad Aghazadeh and James Flynn. The biggest bets by portfolio weight are Kynam Capital Management, LP (6.9%), Sofinnova Investments, Inc. (6.4%) and Great Point Partners LLC (6.1%). In their latest 13Fs, 1 manager opened a new position and 8 added to one.
Superinvestors holding VERA: Behzad Aghazadeh 2.2% · James Flynn 2.1%
| Manager | % of portfolio | Value | Shares | Last quarter | 13F |
|---|---|---|---|---|---|
| Behzad AghazadehHedge fund | 2.2% | $245.6M | 5,723,888 | -2.8% shares | Q2 2026 |
| Deep Track Capital, LPHedge fund | 2.5% | $171.6M | 4,000,000 | -2.6% shares | Q2 2026 |
| James FlynnHedge fund | 2.1% | $168.1M | 3,916,400 | +5.2% shares | Q2 2026 |
| Kynam Capital Management, LPHedge fund | 6.9% | $124.0M | 2,890,059 | -15.0% shares | Q2 2026 |
| Sofinnova Investments, Inc.Hedge fund | 6.4% | $119.9M | 2,793,987 | +0.0% shares | Q2 2026 |
| Eversept Partners, LPHedge fund | 5.2% | $94.9M | 2,212,770 | +1.8% shares | Q2 2026 |
| Logos Global Management LPHedge fund | 4.1% | $94.4M | 2,200,000 | — | Q2 2026 |
| Integral Health Asset Management, LLCHedge fund | 3.1% | $75.1M | 1,750,000 | +9.4% shares | Q2 2026 |
| Bellevue Group AGInvestment manager | 1.5% | $73.4M | 1,710,808 | +0.0% shares | Q2 2026 |
| Great Point Partners LLCHedge fund | 6.1% | $25.8M | 600,836 | +201.4% shares | Q2 2026 |
| Braidwell LPHedge fund | 0.9% | $24.2M | 564,724 | +7.8% shares | Q2 2026 |
| Davern Capital Partners, LPInstitutional asset manager | 3.6% | $21.4M | 498,832 | New | Q2 2026 |
| Elmind Capital, LPHedge fund | 4.7% | $18.7M | 436,518 | -9.5% shares | Q2 2026 |
| Rock Springs Capital Management LPHedge fund | 0.9% | $18.3M | 427,584 | -15.1% shares | Q2 2026 |
| Ikarian Capital, LLCHedge fund | 2.2% | $13.3M | 310,000 | +55.0% shares | Q2 2026 |
| Readystate Asset Management LPHedge fund | 0.8% | $12.7M | 295,114 | — | Q2 2026 |
| Alphabet Inc.Corporation | 0.0% | $10.4M | 241,264 | +0.0% shares | Q2 2026 |
| PFM Health Sciences, LPHedge fund | 0.8% | $9.6M | 224,289 | +28.3% shares | Q2 2026 |
| Platinum Investment Management LtdAsset manager | 1.2% | $4.9M | 113,687 | +0.0% shares | Q2 2026 |
| HighVista Strategies LLCHedge fund | 1.0% | $4.5M | 105,907 | +53.0% shares | Q2 2026 |
| Exome Asset Management LLCHedge fund | 2.6% | $4.2M | 97,276 | -15.4% shares | Q2 2026 |
| Birchview Capital, LPWealth manager | 1.2% | $2.5M | 57,758 | +31.3% shares | Q2 2026 |
| Diadema Partners LPHedge fund | 0.9% | $2.5M | 57,608 | — | Q2 2026 |
| KVP Capital Advisors, LPHedge fund | 1.0% | $1.4M | 32,700 | +0.0% shares | Q2 2026 |
| Knott David M JrInvestment manager | 0.6% | $1.1M | 26,000 | +0.0% shares | Q2 2026 |
| Sectoral Asset Management IncHedge fund | 0.8% | $1.1M | 25,573 | +0.0% shares | Q2 2026 |
| Ami Asset Management CorpWealth manager | 0.1% | $1.0M | 32,028 | +4.7% shares | Q3 2026 |
| Verdad Advisers, LPAsset manager | 1.0% | $1.0M | 23,487 | — | Q2 2026 |
| Ishara Investments LPHedge fund | 0.3% | $440K | 10,250 | -87.5% shares | Q2 2026 |
Each manager counts with its latest 13F (Q3 2026: 1, Q2 2026: 28). Screen VERA in the grand portfolio →
VERA stock trades by members of Congress
No member of Congress has disclosed a trade in VERA.
VERA questions and answers
Are insiders buying VERA stock?
Between Aug 1, 2026 and Oct 29, 2026, 1 VERA insider filed 2 sales worth $1.3M on SEC Form 4, and no open-market purchases; 2 of the sales were pre-planned under Rule 10b5-1.
Which hedge funds own VERA?
29 13F filers hold VERA among their 50 largest positions, worth $1.3B combined, including Behzad Aghazadeh and James Flynn. The biggest bets by portfolio weight are Kynam Capital Management, LP (6.9%), Sofinnova Investments, Inc. (6.4%) and Great Point Partners LLC (6.1%). In their latest 13Fs, 1 manager opened a new position and 8 added to one.
Has Congress traded VERA?
No member of Congress has disclosed a trade in VERA.
Who is the largest holder of VERA?
Among 13F filers, Behzad Aghazadeh reports the largest VERA position, $245.6M (5,723,888 shares) in its Q2 2026 13F. The biggest bet by portfolio weight is Kynam Capital Management, LP's: 6.9% of its portfolio.
Cite or share this
Free to use with a link back. The data updates every filing day.